Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ivax Generic Zoloft Exclusivity Will Be Unaffected By New FDA Guidance

Executive Summary

Ivax expects to retain the full benefit of the 180-day generic exclusivity period for sertraline in 2006 if it prevails in a challenge of two of Pfizer's patents on Zoloft.

You may also be interested in...



Generic Paxil Approved By FDA; Apotex Faces Tricky Launch Decision

Apotex faces an interesting calculation in determining whether and when to launch its generic version of Paxil

Pfizer Zoloft “Authorized” Generic Will Be Available From Ivax By Mid-2006

Ivax will begin distributing an authorized generic version of Pfizer's Zoloft by mid-2006 under an agreement between the two companies

Generic Paxil Approved By FDA; Apotex Faces Tricky Launch Decision

Apotex faces an interesting calculation in determining whether and when to launch its generic version of Paxil

Related Content

UsernamePublicRestriction

Register

OM013164

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel